SCHEMBL2213086

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2213370	0.89	GCK (0.73)	GCKL3MBTL1
	SCHEMBL2208913	0.89	GCK (0.62)	GCKL3MBTL1
	SCHEMBL2212557	0.89	GCK (0.73)	GCKL3MBTL1
	SCHEMBL2213345	0.87	GCK (0.59)	GCKL3MBTL1
	SCHEMBL2664624	0.87	GCK (0.61)	GCKL3MBTL1
	SCHEMBL2208970	0.86	GCK (0.58)	GCKL3MBTL1
	SCHEMBL2212679	0.86	GCK (0.75)	GCKL3MBTL1
	SCHEMBL2642911	0.86	GCK (0.75)	GCK
	SCHEMBL2208947	0.86	GCK (0.58)	GCKL3MBTL1
	SCHEMBL2642681	0.86	GCK (0.60)	GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.